Analysis of the Identification value of multiparametric magnetic resonance imaging in HER-2 low expression versus HER-2-positive breast cancer

Author:

tan feiyi1,zou ziqin2,yang yu1,huang yanfang1

Affiliation:

1. First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

2. Hunan University of Traditional Chinese Medicine

Abstract

Abstract OBJECTIVE: To investigate the differential diagnostic value of magnetic resonance imaging (MRI) between HER-2 low expression and HER-2-positive breast cancer. Methods:We retrospectively analyzed 52 cases of HER-2 low expression breast cancer and 26 cases of HER-2 positive breast cancer treated in our hospital from 2014-01-01 to 2022-04-12. The patients with breast cancer were first examined by MRI and later confirmed by pathological biopsy. The basic clinical case profiles and the characteristics of lesion-related MRI signs were statistically analyzed between the HER-2 low-expressing breast cancer group and the HER-2-positive breast cancer group. RESULTS: The two groups showed statistically significant differences (P<0.05) in the maximum diameter of the mass (P=0.02), internal enhancement features (P=0.048), ADC values (P=0.001), and histological grading (P=0.001). The remaining clinicopathological and magnetic resonance features such as, age, mass distribution, mass morphology, mass margin and TIC curve type were not statistically different (P > 0.05). logistic multivariate regression model showed that: maximum mass diameter, ADC value and histological grade were independent predictors to distinguish between the two types of breast cancer, and mass diameter (≤2 cm) group (OR=0.306, P = 0.027), lower ADC values (OR=331.254, P=0.001), and lower histological grade (OR=5.001, P=0.001) were more likely to be HER-2 low expressing breast cancers. The ROC prediction model incorporating ADC values had good efficacy in discriminating the HER-2 low expression breast cancer group from the HER-2 positive breast cancer group with an area under the curve (AUC) of 0.691. CONCLUSION: There are some differences between the tumor biological characteristics of patients in the HER-2 low expression breast cancer group and the HER-2 positive breast cancer group, and the use of histologic grading, ADC values, maximum diameter of the mass, and other clinical The use of clinical pathological and magnetic resonance features such as histological grading, ADC value, maximum diameter of the mass combined with logistic regression analysis and ROC curve to construct a prediction model can provide some help in the differentiation of the two.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3